
http://www.vistagen.com
VistaGen Therapeutics, Inc. Company Intro
Industry
Healthcare
VistaGen Therapeutics, Inc. Headquaters
343 Allerton Avenue
South San Francisco,94080
United States
VistaGen Therapeutics, Inc. Share price
17 May 2023 14:05 GMT
$0.1380
-0.0 (-1.43 %)
VistaGen Therapeutics, Inc. Market cap
$30.881 M
WMC RANKING
2023
VistaGen Therapeutics, Inc. # 290
BiotechnologyLatest VistaGen Therapeutics, Inc. News
02 Oct 2023
Vistagen prices $100M underwritten offering (NASDAQ:VTGN)
Vistagen Therapeutics (NASDAQ:VTGN) has priced $100M underwritten offering at a combined purchase price of $5.38 per share of common stock, accompanying T1.
02 Oct 2023
VistaGen Therapeutics Announces 100 Million Underwritten Offering for Common Stock and Warrants to Support CNS ...
On October 2, 2023, VistaGen Therapeutics announced the pricing of a significant underwritten offering, totaling $100 million, for its common stock and.
02 Oct 2023
Should Biotechnology Stock Vistagen Therapeutics Inc (VTGN) Be in Your Portfolio Monday?
Vistagen Therapeutics Inc (VTGN) is near the top in its industry group according to InvestorsObserver. VTGN gets an overall rating of 79.
WMC Market Score
WMC Market to Revenue Score
VistaGen Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
VistaGen Therapeutics, Inc. | USD | $1,090 | $19,023 | $-42,320 | $309M | 290 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total VistaGen Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
VistaGen Therapeutics, Inc. Post vs Top 4 Industry Competitors
VistaGen Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
VistaGen Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
VistaGen Therapeutics, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
VistaGen Therapeutics, Inc. | 0.01 | 13.08 | 0.09 | 0 | 0 | 0 | 5.68 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge